Emyria Accelerates National Expansion Following Institutional Placement

Emyria has an $8 million institutional placement to help fund its national expansion program.  The placement was heavily oversubscribed, signalling the strong interest in the Company's work by specialist life-sciences and healthcare-aligned institutional investors, existing supporters, and new strategic entrants. Proceeds of the placement will be used to rapidly deploy Emyria’s East Coast site development plans, expansion of the clinical workforce, and preparatory work for community-based programs for DVA veterans and workers’ compensation cohorts in CY2026.

Insurer-funded treatments have commenced at the Brisbane Empax Clinic within Avive Health’s licensed private hospital this month. Furthermore, as part of its expansion plans, the Company has also exercised its option to enter exclusive negotiations with Avive Health to establish a new Empax Clinic inside Avive’s flagship mental-health hospital in Victoria.

These developments come as national momentum continues to build. Both Medibank and the Department of Veterans’ Affairs have now committed to funding medication-assisted psychotherapy, providing for dual reimbursement pathways for Emyria, and establishing Australia’s first combined private and government funded framework for medication-assisted psychotherapy.

Emyria Executive Chair, Greg Hutchinson, commented:

“With insurer-funded programs now operating in Western Australia and Queensland, and with the DVA now actively supporting treatment for eligible veterans, we are demonstrating that our model of care can scale nationally. The strong backing for our $8 million Placement positions us to accelerate site development, grow our clinical workforce and expand treatment availability for patients living with complex mental-health conditions.”

Click to read the ASX release.